English
Back
Download
Log in to access Online Inquiry
Back to the Top

The USA FDA has approved the listing of the Crexont (carbidopa and levodopa) sustained-release capsules for the treatment of Parkinson's disease (PD).

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
See Original
Report
8592 Views
Comment
Sign in to post a comment
    956
    Followers
    2294
    Following
    8733
    Visitors
    Follow